•
Jun 30, 2016

Jazz Pharmaceuticals Q2 2016 Earnings Report

Total Revenue
$381M
Previous year: $334M
+14.2%
EPS
$2.63
Previous year: $2.41
+9.1%
Gross Profit
$357M
Previous year: $312M
+14.5%
Cash and Equivalents
$868M
Previous year: $922M
-5.8%
Total Assets
$3.45B
Previous year: $3.39B
+1.6%

Jazz Pharmaceuticals

Jazz Pharmaceuticals